• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA 损伤强度调节了 p53 动力学的双峰开关,用于细胞命运控制。

DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control.

机构信息

Center for Quantitative Systems Biology and Department of Physics, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong, China.

出版信息

BMC Biol. 2013 Jun 21;11:73. doi: 10.1186/1741-7007-11-73.

DOI:10.1186/1741-7007-11-73
PMID:23800173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3702437/
Abstract

BACKGROUND

The p53 pathway is differentially activated in response to distinct DNA damage, leading to alternative phenotypic outcomes in mammalian cells. Recent evidence suggests that p53 expression dynamics play an important role in the differential regulation of cell fate, but questions remain as to how p53 dynamics and the subsequent cellular response are modulated by variable DNA damage.

RESULTS

We identified a novel, bimodal switch of p53 dynamics modulated by DNA-damage strength that is crucial for cell-fate control. After low DNA damage, p53 underwent periodic pulsing and cells entered cell-cycle arrest. After high DNA damage, p53 underwent a strong monotonic increase and cells activated apoptosis. We found that the damage dose-dependent bimodal switch was due to differential Mdm2 upregulation, which controlled the alternative cell fates mainly by modulating the induction level and pro-apoptotic activities of p53.

CONCLUSIONS

Our findings not only uncover a new mode of regulation for p53 dynamics and cell fate, but also suggest that p53 oscillation may function as a suppressor, maintaining a low level of p53 induction and pro-apoptotic activities so as to render cell-cycle arrest that allows damage repair.

摘要

背景

p53 途径会针对不同的 DNA 损伤而呈现差异化激活,从而导致哺乳动物细胞出现不同的表型结果。最近的证据表明,p53 表达的动态变化在细胞命运的差异化调控中起着重要作用,但仍存在一些问题,即 p53 动力学及其后续的细胞反应是如何受到可变 DNA 损伤的调节的。

结果

我们发现了一种新的、由 DNA 损伤强度调节的 p53 动力学双模态开关,这对细胞命运控制至关重要。在低 DNA 损伤后,p53 经历周期性脉冲,细胞进入细胞周期停滞。在高 DNA 损伤后,p53 经历强烈的单调增加,细胞激活凋亡。我们发现,这种损伤剂量依赖性的双模态开关是由于 Mdm2 的差异上调所致,Mdm2 主要通过调节 p53 的诱导水平和促凋亡活性来控制细胞命运的替代。

结论

我们的发现不仅揭示了 p53 动力学和细胞命运的一种新的调控模式,还表明 p53 振荡可能作为一种抑制物发挥作用,维持低水平的 p53 诱导和促凋亡活性,从而使细胞周期停滞,以允许损伤修复。

相似文献

1
DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control.DNA 损伤强度调节了 p53 动力学的双峰开关,用于细胞命运控制。
BMC Biol. 2013 Jun 21;11:73. doi: 10.1186/1741-7007-11-73.
2
A plausible model for bimodal p53 switch in DNA damage response.双模态 p53 开关在 DNA 损伤反应中的一个合理模型。
FEBS Lett. 2014 Mar 3;588(5):815-21. doi: 10.1016/j.febslet.2014.01.044. Epub 2014 Jan 31.
3
Cell type-dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance.细胞类型依赖性的双模态 p53 激活产生了一种动态的化疗抵抗机制。
Sci Adv. 2018 Dec 19;4(12):eaat5077. doi: 10.1126/sciadv.aat5077. eCollection 2018 Dec.
4
A two-step mechanism for cell fate decision by coordination of nuclear and mitochondrial p53 activities.通过细胞核和线粒体p53活性的协调作用进行细胞命运决定的两步机制。
PLoS One. 2012;7(6):e38164. doi: 10.1371/journal.pone.0038164. Epub 2012 Jun 5.
5
MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response.MicroRNA-16与p53和Wip1形成的反馈回路可在DNA损伤反应中调节细胞凋亡和衰老之间的命运决定。
PLoS One. 2017 Oct 2;12(10):e0185794. doi: 10.1371/journal.pone.0185794. eCollection 2017.
6
p53 requires the stress sensor USF1 to direct appropriate cell fate decision.p53 需要应激传感器 USF1 来指导适当的细胞命运决定。
PLoS Genet. 2014 May 15;10(5):e1004309. doi: 10.1371/journal.pgen.1004309. eCollection 2014.
7
Cell fate decision mediated by p53 pulses.由p53脉冲介导的细胞命运决定。
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12245-50. doi: 10.1073/pnas.0813088106. Epub 2009 Jul 15.
8
Two-phase dynamics of p53 in the DNA damage response.p53 在 DNA 损伤反应中的两相动力学。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):8990-5. doi: 10.1073/pnas.1100600108. Epub 2011 May 16.
9
ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.ATM 通过抑制 DNA 损伤诱导的凋亡反应中的 MDM2 来增强 DYRK2 的核稳定。
J Biol Chem. 2010 Feb 12;285(7):4909-19. doi: 10.1074/jbc.M109.042341. Epub 2009 Dec 4.
10
Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.药物抑制 Mdm2 会引发小鼠结肠肿瘤和人结肠癌细胞的生长停滞,并促进 DNA 断裂。
Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795. Epub 2011 May 6.

引用本文的文献

1
Regulatory Interplay of p53, AMPK, and mTOR in Decidualization: Implications for Reproductive Competence and Cancer Biology.p53、AMPK和mTOR在蜕膜化过程中的调节相互作用:对生殖能力和癌症生物学的影响
Reprod Sci. 2025 Sep 4. doi: 10.1007/s43032-025-01970-z.
2
Decoding stimulus-specific regulation of promoter activity of p53 target genes.解码p53靶基因启动子活性的刺激特异性调控
Front Cell Dev Biol. 2025 Jun 13;13:1603603. doi: 10.3389/fcell.2025.1603603. eCollection 2025.
3
Genotoxic consequences of viral infections.病毒感染的遗传毒性后果。

本文引用的文献

1
Attractor landscape analysis reveals feedback loops in the p53 network that control the cellular response to DNA damage.吸引子景观分析揭示了 p53 网络中的反馈回路,这些回路控制着细胞对 DNA 损伤的反应。
Sci Signal. 2012 Nov 20;5(251):ra83. doi: 10.1126/scisignal.2003363.
2
p53 dynamics control cell fate.p53 动态控制细胞命运。
Science. 2012 Jun 15;336(6087):1440-4. doi: 10.1126/science.1218351.
3
Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.p53 的基础动力学揭示了细胞周期中转录衰减的脉冲。
Npj Viruses. 2025 Jan 27;3(1):5. doi: 10.1038/s44298-024-00087-5.
4
Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes.全面的生物信息学研究揭示了不同癌症图谱中 TP53 的失调
Genes (Basel). 2024 Apr 30;15(5):577. doi: 10.3390/genes15050577.
5
The Sweet Side of HIPK2.HIPK2的甜蜜一面。
Cancers (Basel). 2023 May 9;15(10):2678. doi: 10.3390/cancers15102678.
6
Encoding and Decoding of p53 Dynamics in Cellular Response to Stresses.编码和解码细胞对应激反应中 p53 动力学。
Cells. 2023 Feb 2;12(3):490. doi: 10.3390/cells12030490.
7
Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers.核仁应激反应通过核糖体蛋白 L11 调节 P53 完整型癌症对拓扑异构酶抑制剂的敏感性。
Int J Mol Sci. 2022 Dec 15;23(24):15986. doi: 10.3390/ijms232415986.
8
DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities.重新审视 DNA 损伤反应:p53 家族及其调控因子为癌症治疗提供了无尽的机会。
Exp Mol Med. 2022 Oct;54(10):1658-1669. doi: 10.1038/s12276-022-00863-4. Epub 2022 Oct 7.
9
Single-cell analysis of p53 transitional dynamics unravels stimulus- and cell type-dependent signaling output motifs.单细胞分析 p53 转变动力学揭示了刺激和细胞类型依赖性信号输出模式。
BMC Biol. 2022 Apr 11;20(1):85. doi: 10.1186/s12915-022-01290-7.
10
Dual roles of SIRT1 in the BAX switch through the P53 module: A mathematical modeling study.通过P53模块,SIRT1在BAX开关中的双重作用:一项数学建模研究。
Comput Struct Biotechnol J. 2021 Oct 2;19:5578-5588. doi: 10.1016/j.csbj.2021.09.033. eCollection 2021.
Cell. 2010 Jul 9;142(1):89-100. doi: 10.1016/j.cell.2010.05.031.
4
Decision Making by p53: Life versus Death.p53的决策:生或死
Mol Cell Pharmacol. 2010 Jan 1;2(2):69-77.
5
YPEL3, a p53-regulated gene that induces cellular senescence.YPEL3,一个受 p53 调控的诱导细胞衰老的基因。
Cancer Res. 2010 May 1;70(9):3566-75. doi: 10.1158/0008-5472.CAN-09-3219. Epub 2010 Apr 13.
6
Tumour suppression by p53: a role for the DNA damage response?p53介导的肿瘤抑制作用:DNA损伤反应起作用吗?
Nat Rev Cancer. 2009 Oct;9(10):714-23. doi: 10.1038/nrc2716. Epub 2009 Sep 4.
7
Modes of p53 regulation.p53的调控模式。
Cell. 2009 May 15;137(4):609-22. doi: 10.1016/j.cell.2009.04.050.
8
Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis.RITA 重新激活的 p53 对关键致癌途径的消融是有效凋亡所必需的。
Cancer Cell. 2009 May 5;15(5):441-53. doi: 10.1016/j.ccr.2009.03.021.
9
Cytoplasmic functions of the tumour suppressor p53.肿瘤抑制因子p53的细胞质功能
Nature. 2009 Apr 30;458(7242):1127-30. doi: 10.1038/nature07986.
10
Targeting DNA topoisomerase II in cancer chemotherapy.癌症化疗中靶向DNA拓扑异构酶II
Nat Rev Cancer. 2009 May;9(5):338-50. doi: 10.1038/nrc2607. Epub 2009 Apr 20.